META Stock - Meta Platforms, Inc.
Unlock GoAI Insights for META
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $164.50B | $134.90B | $116.61B | $117.93B | $85.97B |
| Gross Profit | $134.34B | $108.94B | $91.36B | $95.28B | $69.27B |
| Gross Margin | 81.7% | 80.8% | 78.3% | 80.8% | 80.6% |
| Operating Income | $69.38B | $46.75B | $28.94B | $46.75B | $32.67B |
| Net Income | $62.36B | $39.10B | $23.20B | $39.37B | $29.15B |
| Net Margin | 37.9% | 29.0% | 19.9% | 33.4% | 33.9% |
| EPS | $24.61 | $15.19 | $8.63 | $13.99 | $10.22 |
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 4th 2025 | Arete | Upgrade | Buy | $718 |
| November 24th 2025 | BNP Paribas Exane | Initiation | Outperform | $800 |
| November 10th 2025 | Erste Group | Downgrade | Hold | - |
| October 30th 2025 | Jefferies | Reiterated | Buy | $910← $950 |
| October 30th 2025 | Barclays | Reiterated | Overweight | $770← $810 |
| October 30th 2025 | BofA Securities | Reiterated | Buy | $810← $900 |
| October 30th 2025 | Bernstein | Reiterated | Outperform | $870← $900 |
| October 30th 2025 | Piper Sandler | Reiterated | Overweight | $840← $880 |
| October 30th 2025 | Mizuho | Reiterated | Outperform | $815← $925 |
| October 30th 2025 | Stifel | Reiterated | Buy | $875← $900 |
| October 30th 2025 | Citigroup | Reiterated | Buy | $850← $915 |
| October 30th 2025 | JP Morgan | Reiterated | Overweight | $800← $875 |
| October 30th 2025 | Monness Crespi & Hardt | Reiterated | Buy | $808← $860 |
| October 30th 2025 | Oppenheimer | Downgrade | Perform | - |
| October 30th 2025 | The Benchmark Company | Downgrade | Hold | - |
Earnings History & Surprises
METAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $8.15 | — | — | — |
Q4 2025 | Oct 29, 2025 | $6.72 | $7.25 | +7.9% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $5.88 | $7.14 | +21.4% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $5.23 | $6.43 | +22.9% | ✓ BEAT |
Q1 2025 | Jan 29, 2025 | $6.75 | $8.02 | +18.8% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $5.25 | $6.03 | +14.9% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $4.73 | $5.16 | +9.1% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $4.32 | $4.71 | +9.0% | ✓ BEAT |
Q1 2024 | Feb 1, 2024 | $4.96 | $5.33 | +7.5% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $3.63 | $4.39 | +20.9% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $2.92 | $2.98 | +2.1% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $2.03 | $2.20 | +8.4% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $2.22 | $1.76 | -20.7% | ✗ MISS |
Q4 2022 | Oct 26, 2022 | $1.89 | $1.64 | -13.2% | ✗ MISS |
Q3 2022 | Jul 27, 2022 | $2.59 | $2.46 | -5.0% | ✗ MISS |
Q2 2022 | Apr 27, 2022 | $2.56 | $2.72 | +6.3% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $3.84 | $3.67 | -4.4% | ✗ MISS |
Q4 2021 | Oct 25, 2021 | $3.19 | $3.22 | +0.9% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $3.03 | $3.61 | +19.1% | ✓ BEAT |
Latest News
'Meta Board Member Powell McCormick Resigns After Eight Months'- Bloomberg
📉 NegativeWedbush Maintains Outperform on Meta Platforms, Lowers Price Target to $880
📈 Positive'Meta Developing New AI Image and Video Model Code-Named 'Mango''- WSJ
📈 PositiveMeta Ordered By Austrian Supreme Court To Provide Full Access To All Personal Data Of Users Within 14 Days
📉 Negative'Google works to erode Nvidia's software advantage with Meta's help'- Reuters Exclusive
➖ NeutralInstagram Posts On Threads "Introducing Instagram for TV. We're starting a test that brings reels to a bigger screen, so you can watch with your friends.
📈 PositiveMeta Introduces Sam Audio, A State-Of-The-Art AI Model That Enables You To Segment Sound
📈 PositiveDisney+ Brings A Massive Catalog Of Entertainment Content To Meta Quest Today In the US
📈 PositiveMeta Platforms' Delaware Derivative Lawsuit Settlement Hearing Scheduled For April 7, 2026
➖ Neutral'Musk's X Posts Higher Sales Amid Costly Turnaround' - Bloomberg News
📈 PositiveCastle Biosciences Says Systematic Review And Meta-Analysis In Journal Of Clinical Gastroenterology Finds TissueCypher Barrett's Esophagus Test Outperforms Pathology And Clinical Factors, With High-Risk Results Linked To 6.7x Higher Five-Year Progression To HGD Or Esophageal Adenocarcinoma
📈 PositiveMorgan Stanley Maintains Overweight on Meta Platforms, Lowers Price Target to $750
➖ NeutralReported Earlier: 'Inside Meta's Pivot From Open Source to Money-Making AI Model' - Bloomberg News
➖ NeutralAlibaba Shares Higher On Reports Suggesting Meta Is Using Co.'s Qwen
📈 PositiveBusiness Insider: Meta is planning price hikes for its virtual reality devices, internal memo shows
📈 Positive'Meta's Shifting AI Strategy Is Causing Internal Confusion' - CNBC Exclusive
📉 NegativeEuropean Commission Acknowledges Meta's Undertaking to Offer EU Users Alternative Facebook and Instagram Services With Less Personalised Ads to Comply With Digital Markets Act
📈 PositiveUPDATE: Co-Founder & CEO Of LimitlessAI Dan Siroker Says "Limitless Has Been Acquired By Meta"
📈 PositiveUSA TODAY shares are trading higher after the company announced a multi-year strategic partnership with Meta to access new and archival content from USA TODAY.
📈 PositiveIAC's Operating Business People Inc. Announces Strategic Content Partnership With Meta As Lifestyle Publisher To Make Real-Time Content Available To Meta AI Users
📈 PositiveFrequently Asked Questions about META
What is META's current stock price?
What is the analyst price target for META?
What sector is Meta Platforms, Inc. in?
What is META's market cap?
Does META pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to META for comparison